查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1649478

OTC 睡眠輔助劑市場預測（2025-2030 年）

Otc Sleep Aids Medication Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

非處方睡眠輔助藥物市場預計將以 4.89% 的複合年成長率成長，從 2025 年的 201.05 億美元成長至 2030 年的 255.26 億美元。

非處方（OTC）睡眠輔助劑是無需處方箋即可購買的用於治療失眠或睡眠不足的藥物。如果失眠現像不頻繁，通常建議使用這些藥物。常用的非處方助眠藥包括苯海拉明、多西拉敏、褪黑激素和纈草。這些產品的市場包括 Unison SleepTabs、ZzzQuil、Tylenol、Nytol 和 Sominex 等知名品牌。非處方睡眠輔助藥物市場包括非處方箋睡眠藥物和天然補充劑的生產、分銷和銷售，用於治療偶爾失眠、輕度失眠、暫時性睡眠障礙、時差和一般煩躁不安。這個市場包括抗組織胺、褪黑激素補充劑以及纈草根和洋甘菊等草藥。非處方睡眠輔助藥物市場的成長受到多種因素的推動。睡眠障礙盛行率的上升很大程度上是由於現代生活方式的改變，例如壓力、焦慮、不規則的工作時間以及過多的螢幕時間。由於這些因素，睡眠障礙很常見。隨著人們越來越意識到睡眠健康的重要性，對安眠藥和天然補充品來解決睡眠問題的需求也越來越大。此外，非處方藥供應的增加也促進了該市場的持續成長。此外，天然和草本助眠劑的流行趨勢明顯，預計將進一步推動市場成長。

OTC睡眠輔助劑市場促進因素：

  • 睡眠障礙盛行率上升：現代生活方式以壓力、焦慮、工作壓力和過多螢幕時間為特徵，導致患有失眠和異睡症等睡眠障礙的人數顯著增加。根據美國國家心肺血液研究所的資料，大約有 5,000 萬至 7,000 萬美國人患有睡眠或覺醒障礙。此外，成人慢性失眠評估和管理臨床指引估計，約 33% 至 50% 的成年人面臨情境壓力。這些統計數據顯示失眠呈成長趨勢，並預示非處方睡眠輔助藥物市場在未來幾年將大幅成長。

非處方睡眠輔助劑市場的地理模式：

  • 亞太地區預計成長最快：非處方睡眠輔助藥物市場分為北美、南美、歐洲、中東和非洲以及亞太地區。由於與現代生活方式相關的睡眠障礙病例不斷增加，預計亞太地區將成為預測期內成長最快的地區。經濟狀況的改善使得消費者有能力購買這些藥物。此外，人們對睡眠相關疾病及其治療方法的認知也得到了提升。

另一方面，北美由於其發達的醫療保健基礎設施預計將保持較大的市場佔有率。總而言之，隨著人們對睡眠健康問題的認知不斷提高、對針對失眠和相關疾病的有效解決方案的需求不斷增加、產品配方的進步以及特別是在亞太地區的重大發展，非處方睡眠輔助市場將迎來強勁成長。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 細分和區域分析，包括收益成長和預測國家
  • 公司概況（策略、產品、財務、主要發展等）

OTC 睡眠輔助藥物市場細分如下：

按類型

  • 抗組織胺藥物
  • 褪黑激素補充劑
  • 草藥補充劑
  • 其他

按應用

  • 失眠治療
  • 緩解焦慮
  • 其他

按分銷管道

  • 線上
  • 超級市場/大賣場
  • 藥局和藥局
  • 專賣店

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 韓國
  • 澳洲
  • 印度
  • 印尼
  • 泰國
  • 其他

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

5. 非處方睡眠輔助藥物市場按類型

  • 介紹
  • 抗組織胺藥
  • 褪黑激素補充劑
  • 草藥補充劑
  • 其他

6. 非處方睡眠輔助產品市場（依應用）

  • 介紹
  • 失眠治療
  • 緩解焦慮
  • 其他

7. 非處方睡眠輔助產品市場（依分銷管道）

  • 介紹
  • 線上
  • 超級市場/大賣場
  • 藥局和藥局
  • 專賣店

8. 非處方睡眠輔助藥物市場（按地區）

  • 介紹
  • 北美洲
    • 按類型
    • 按應用
    • 按分銷管道
    • 按國家
  • 南美洲
    • 按類型
    • 按應用
    • 按分銷管道
    • 按國家
  • 歐洲
    • 按類型
    • 按應用
    • 按分銷管道
    • 按國家
  • 中東和非洲
    • 按類型
    • 按應用
    • 按分銷管道
    • 按國家
  • 亞太地區
    • 按類型
    • 按應用
    • 按分銷管道
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Pfizer Inc.
  • Sanofi SA
  • Johnson and Johnson
  • Reckitt Benckiser
  • Sundown Naturals
  • Proctor and Gamble
  • Bayer AG
  • Unilever
簡介目錄
Product Code: KSI061617252

The OTC Sleep Aids Medication Market is expected to grow at a CAGR of 4.89%, reaching a market size of US$25.526 billion in 2030 from US$20.105 billion in 2025

Over-the-counter (OTC) sleep aid medications are drugs available without a prescription, designed to help with occasional sleeplessness or insomnia. These medications are typically recommended for treating infrequent sleepless nights. Commonly used OTC sleep aids include diphenhydramine, doxylamine, melatonin, and valerian. The market for these products features well-known brands such as Unison SleepTabs, ZzzQuil, Tylenol, Nytol, and Sominex.The OTC sleep aids medication market encompasses the production, distribution, and sale of nonprescription sleeping pills and natural supplements aimed at managing occasional sleeplessness, mild insomnia, temporary sleep disturbances, jet lag, and general restlessness. This market includes antihistamine-based medications, melatonin supplements, and herbal remedies like valerian root and chamomile.The growth of the OTC sleep aid medication market is driven by several factors. The rising prevalence of sleep disorders is largely attributed to modern lifestyle changes such as stress, anxiety, irregular work schedules, and excessive screen time. These factors have led to an increase in sleep disorders becoming common. As people become more aware of the importance of sleep health, there is a growing demand for sleeping pills or natural supplements to address their sleep issues. Additionally, the accessibility of OTC medications contributes to the continued growth of this market. Furthermore, there is a notable trend toward natural and herbal sleep aid medications that is expected to further boost market growth.

Drivers of the OTC Sleep Aids Medication Market:

  • Rising Prevalence of Sleep Disorders: The modern lifestyle characterized by stress, anxiety, work pressure, and excessive screen time has led to a significant increase in individuals suffering from sleep disorders such as insomnia and parasomnia. According to data from the National Heart, Lung, and Blood Institute, approximately 50 to 70 million Americans experience sleep or wakefulness disorders. Additionally, the clinical guidelines for evaluating and managing chronic insomnia in adults estimate that around 33% to 50% of the adult population faces situational stress. These statistics indicate a growing trend in sleeplessness and suggest that the OTC sleep aid medication market will see substantial growth in the coming years.

Geographical Outlook of the OTC Sleep Aids Medication Market:

  • Asia-Pacific Expected to Be the Fastest-Growing Region: The OTC sleep aids medication market is segmented into North America, South America, Europe, the Middle East & Africa, and Asia-Pacific. During the forecast period, Asia-Pacific is projected to be the fastest-growing region due to increasing cases of sleep disorders linked to modern lifestyles. Rising economic conditions are enabling consumers to afford these medications. Additionally, there is heightened awareness among individuals regarding sleep-related disorders and their treatment options.

In contrast, North America is expected to maintain a significant share of the market due to its advanced healthcare infrastructure. The high prevalence of sleep disorders and supportive infrastructure for medication access are key factors driving market growth in this region.In summary, the OTC sleep aid medication market is poised for robust growth driven by increasing awareness of sleep health issues, rising demand for effective solutions targeting insomnia and related disorders, advancements in product formulations, and significant geographical developments-particularly within Asia-Pacific-that enhance this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The OTC Sleep Aids Medication Market has been segmented as following:

By Type

  • Antihistamine
  • Melatonin Supplements
  • Herbal Supplement
  • Others

By Application

  • Insomnia Treatment
  • Anxiety Relief
  • Others

By Distribution Channel

  • Online
  • Supermarkets/Hypermarkets
  • Pharmacies and Drugstores
  • Specialty Stores

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. OTC SLEEP AIDS MEDICATION MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Antihistamine
  • 5.3. Melatonin Supplements
  • 5.4. Herbal Supplements
  • 5.5. Others

6. OTC SLEEP AIDS MEDICATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Insomnia Treatment
  • 6.3. Anxiety Relief
  • 6.4. Others

7. OTC SLEEP AIDS MEDICATION MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Supermarkets/Hypermarkets
  • 7.4. Pharmacies and Drugstores
  • 7.5. Specialty Stores

8. OTC SLEEP AIDS MEDICATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. Australia
      • 8.6.4.5. India
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Pfizer Inc.
  • 10.2. Sanofi S.A.
  • 10.3. Johnson and Johnson
  • 10.4. Reckitt Benckiser
  • 10.5. Sundown Naturals
  • 10.6. Proctor and Gamble
  • 10.7. Bayer AG
  • 10.8. Unilever